Luke Basil Evnin, MPM Capital

Luke Basil Evnin, Co-Founder & Managing Director at MPM Capital, Cambridge, MA — verified investor profile. See sector focus and contact routes.

About Luke Basil Evnin

Luke Evnin, Ph.D., is a co-founder and Managing Director of MPM Capital (now MPM BioImpact), a life sciences venture firm he established in 1997 with Ansbert Gadicke after seven years at Accel Partners. His investment thesis targets global opportunities across all stages from pre-seed to late-stage, focusing on biotech, pharmaceuticals, medical devices, digital health, and healthcare services. Evnin typically invests between $1 million and $150 million and has served as the lead partner on 41 deals while co-founding multiple portfolio companies. Notable portfolio companies include Werewolf Therapeutics, Harpoon Therapeutics, Syndax Pharmaceuticals, and Photys Therapeutics, for which he has held board or executive roles. A distinctive point of view stems from his personal experience as a scleroderma patient, driving his advocacy for drug development in rare autoimmune diseases through initiatives like the Conquest clinical trial platform. He holds a Ph.D. in Biochemistry from UCSF and has served on over 30 public and private life science company boards.

Luke Basil Evnin at a glance

Role
Co-Founder & Managing Director
Organization
MPM Capital
Location
Cambridge, MA
Investor type
Venture Capital
Focus areas
Healthcare Devices and Supplies, Pharmaceuticals and Biotechnology, Software

Frequently asked about Luke Basil Evnin

What does Luke Basil Evnin invest in?
Luke Basil Evnin at MPM Capital (Cambridge, MA) — sector focus: Healthcare Devices and Supplies, Pharmaceuticals and Biotechnology, Software.
How do I contact Luke Basil Evnin?
Luke Basil Evnin's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Luke Basil Evnin based?
Luke Basil Evnin is based in Cambridge, MA.

StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Cambridge.

Investors similar to Luke Basil Evnin (20)

Browse related investor lists (2)

Compare Luke Basil Evnin (8)

Investors like Luke Basil Evnin · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades